Outcome of chickenpox in 66 pediatric renal transplant recipients

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Although chickenpox can cause severe morbidity and mortality in pediatric renal transplant recipients, published reports describing treatment of these patients are few, especially in the cyclosporine era. Sixty-nine episodes of chickenpox occurring in 66 patients were diagnosed in our transplant population between January 1984 and May 1996. Immunosuppression consisted of prednisone and azathioprine (30 cases); prednisone, azathioprine, and cyclosporine (38 cases); or prednisone alone (1 case). Azathioprine was temporarily discontinued in 66 of 68 cases. Cyclosporine was continued at the preexisting dose in 36 of 38 cases. Acyclovir was administered parenterally in 62 of 69 cases. Sixty-five of 66 patients survived. Cyclosporine use did not increase the incidence of severe disease (p > 0.1). Acute allograft rejection occurred in three patients and responded to prednisone. Chickenpox in children with renal transplants can be successfully treated with intravenous acyclovir and temporary withdrawal of azathioprine. Allograft rejection is uncommon with this approach. Patients receiving cyclosporine do not appear to experience increased morbidity or mortality with chickenpox.

Original languageEnglish (US)
Pages (from-to)874-877
Number of pages4
JournalJournal of Pediatrics
Volume131
Issue number6
DOIs
StatePublished - Jan 1 1997

Fingerprint

Chickenpox
Cyclosporine
Azathioprine
Prednisone
Pediatrics
Kidney
Acyclovir
Allografts
Morbidity
Transplants
Mortality
Immunosuppression
Transplant Recipients
Incidence
Population

Cite this

Outcome of chickenpox in 66 pediatric renal transplant recipients. / Kashtan, Clifford; Cook, M.; Chavers, Blanche M; Mauer, Michael; Nevins, Thomas E.

In: Journal of Pediatrics, Vol. 131, No. 6, 01.01.1997, p. 874-877.

Research output: Contribution to journalArticle

@article{96658247ead746b4a862f83adeb69ad3,
title = "Outcome of chickenpox in 66 pediatric renal transplant recipients",
abstract = "Although chickenpox can cause severe morbidity and mortality in pediatric renal transplant recipients, published reports describing treatment of these patients are few, especially in the cyclosporine era. Sixty-nine episodes of chickenpox occurring in 66 patients were diagnosed in our transplant population between January 1984 and May 1996. Immunosuppression consisted of prednisone and azathioprine (30 cases); prednisone, azathioprine, and cyclosporine (38 cases); or prednisone alone (1 case). Azathioprine was temporarily discontinued in 66 of 68 cases. Cyclosporine was continued at the preexisting dose in 36 of 38 cases. Acyclovir was administered parenterally in 62 of 69 cases. Sixty-five of 66 patients survived. Cyclosporine use did not increase the incidence of severe disease (p > 0.1). Acute allograft rejection occurred in three patients and responded to prednisone. Chickenpox in children with renal transplants can be successfully treated with intravenous acyclovir and temporary withdrawal of azathioprine. Allograft rejection is uncommon with this approach. Patients receiving cyclosporine do not appear to experience increased morbidity or mortality with chickenpox.",
author = "Clifford Kashtan and M. Cook and Chavers, {Blanche M} and Michael Mauer and Nevins, {Thomas E}",
year = "1997",
month = "1",
day = "1",
doi = "10.1016/S0022-3476(97)70036-2",
language = "English (US)",
volume = "131",
pages = "874--877",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Outcome of chickenpox in 66 pediatric renal transplant recipients

AU - Kashtan, Clifford

AU - Cook, M.

AU - Chavers, Blanche M

AU - Mauer, Michael

AU - Nevins, Thomas E

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Although chickenpox can cause severe morbidity and mortality in pediatric renal transplant recipients, published reports describing treatment of these patients are few, especially in the cyclosporine era. Sixty-nine episodes of chickenpox occurring in 66 patients were diagnosed in our transplant population between January 1984 and May 1996. Immunosuppression consisted of prednisone and azathioprine (30 cases); prednisone, azathioprine, and cyclosporine (38 cases); or prednisone alone (1 case). Azathioprine was temporarily discontinued in 66 of 68 cases. Cyclosporine was continued at the preexisting dose in 36 of 38 cases. Acyclovir was administered parenterally in 62 of 69 cases. Sixty-five of 66 patients survived. Cyclosporine use did not increase the incidence of severe disease (p > 0.1). Acute allograft rejection occurred in three patients and responded to prednisone. Chickenpox in children with renal transplants can be successfully treated with intravenous acyclovir and temporary withdrawal of azathioprine. Allograft rejection is uncommon with this approach. Patients receiving cyclosporine do not appear to experience increased morbidity or mortality with chickenpox.

AB - Although chickenpox can cause severe morbidity and mortality in pediatric renal transplant recipients, published reports describing treatment of these patients are few, especially in the cyclosporine era. Sixty-nine episodes of chickenpox occurring in 66 patients were diagnosed in our transplant population between January 1984 and May 1996. Immunosuppression consisted of prednisone and azathioprine (30 cases); prednisone, azathioprine, and cyclosporine (38 cases); or prednisone alone (1 case). Azathioprine was temporarily discontinued in 66 of 68 cases. Cyclosporine was continued at the preexisting dose in 36 of 38 cases. Acyclovir was administered parenterally in 62 of 69 cases. Sixty-five of 66 patients survived. Cyclosporine use did not increase the incidence of severe disease (p > 0.1). Acute allograft rejection occurred in three patients and responded to prednisone. Chickenpox in children with renal transplants can be successfully treated with intravenous acyclovir and temporary withdrawal of azathioprine. Allograft rejection is uncommon with this approach. Patients receiving cyclosporine do not appear to experience increased morbidity or mortality with chickenpox.

UR - http://www.scopus.com/inward/record.url?scp=0031455577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031455577&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(97)70036-2

DO - 10.1016/S0022-3476(97)70036-2

M3 - Article

C2 - 9427893

AN - SCOPUS:0031455577

VL - 131

SP - 874

EP - 877

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 6

ER -